Mouwasat Medical Services Company SJSC
SAU:4002
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/EBITDA
Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Valuation Scenarios
If EV/EBITDA returns to its 3-Year Average (14.7), the stock would be worth ﷼113.18 (8% upside from current price).
| Scenario | EV/EBITDA Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 13.5 | ﷼104.4 |
0%
|
| 3-Year Average | 14.7 | ﷼113.18 |
+8%
|
| 5-Year Average | 15.4 | ﷼118.85 |
+14%
|
| Industry Average | 17.7 | ﷼136.09 |
+30%
|
| Country Average | 14.5 | ﷼111.5 |
+7%
|
Forward EV/EBITDA
Today’s price vs future ebitda
| Today's Enterprise Value | EBITDA | Forward EV/EBITDA | ||
|---|---|---|---|---|
|
﷼14.4B
|
/ |
Oct 2025
﷼1.1B
|
= |
|
|
﷼14.4B
|
/ |
Dec 2025
﷼1.1B
|
= |
|
|
﷼14.4B
|
/ |
Dec 2026
﷼934.5m
|
= |
|
|
﷼14.4B
|
/ |
Dec 2027
﷼945.9m
|
= |
|
|
﷼14.4B
|
/ |
Dec 2028
﷼795.1m
|
= |
|
Forward EV/EBITDA shows whether today’s EV/EBITDA still looks high or low once future ebitda are taken into account.
Peer Comparison
| Market Cap | EV/EBITDA | P/E | ||||
|---|---|---|---|---|---|---|
| SA |
|
Mouwasat Medical Services Company SJSC
SAU:4002
|
13.9B SAR | 13.5 | 18.4 | |
| US |
|
HCA Healthcare Inc
NYSE:HCA
|
109.1B USD | 9.4 | 15.8 | |
| SA |
|
Dr Sulaiman Al-Habib Medical Services Group Co
SAU:4013
|
98B SAR | 31.9 | 40.8 | |
| ZA |
N
|
Netcare Ltd
JSE:NTC
|
24.1B ZAR | 9.5 | 14.3 | |
| MY |
I
|
IHH Healthcare Bhd
KLSE:IHH
|
77.6B MYR | 15.2 | 36.9 | |
| ZA |
L
|
Life Healthcare Group Holdings Ltd
JSE:LHC
|
18.1B ZAR | 18.5 | 4.7 | |
| BR |
|
Rede D'Or Sao Luiz SA
BOVESPA:RDOR3
|
87B BRL | 7.9 | 18.6 | |
| US |
|
Tenet Healthcare Corp
NYSE:THC
|
16.6B USD | 5.6 | 11.5 | |
| CN |
A
|
Aier Eye Hospital Group Co Ltd
SZSE:300015
|
90.2B CNY | 20.1 | 28 | |
| IN |
|
Apollo Hospitals Enterprise Ltd
NSE:APOLLOHOSP
|
1.1T INR | 29.9 | 61.7 | |
| US |
|
Ensign Group Inc
NASDAQ:ENSG
|
11.5B USD | 20 | 32 |
Market Distribution
| Min | 1.5 |
| 30th Percentile | 11.1 |
| Median | 14.5 |
| 70th Percentile | 20.1 |
| Max | 24 279.8 |
Other Multiples
Mouwasat Medical Services Company SJSC
Glance View
In the heart of Saudi Arabia, Mouwasat Medical Services Company SJSC stands as a beacon of healthcare excellence, reflecting the dynamic growth and modernization of the nation's medical infrastructure. Born in 1975, Mouwasat embarked on its journey with a vision to provide premium healthcare services, driven by a meticulous focus on patient care and technological advancement. The company has come a long way from its humble beginnings, now operating a robust network of hospitals and medical centers across the Kingdom. Rooted in its commitment to quality, Mouwasat thrives by offering comprehensive healthcare services, from inpatient and outpatient care to specialized medical treatments. This diversified healthcare ecosystem is bolstered by strategic investments in cutting-edge medical technology and a dedicated team of healthcare professionals, enhancing its reputation as a leader in the sector. Mouwasat's financial engine hums not only on a traditional fee-for-service model but also on forging partnerships with corporate clients and governmental bodies. This dual approach allows the company to stabilize its revenue streams, ensuring a diversified and steady flow of income. By extensively collaborating with insurers, Mouwasat optimizes patient accessibility while widening its market reach, thus reinforcing its profit margins. Furthermore, the firm remains agile, consistently expanding its capacity through investment in new facilities and strategic geographic locations, aiming to capture the growing healthcare demand. Embedded deeply in its operating ethos is a customer-centric philosophy, which not only fuels patient satisfaction but also cultivates long-term loyalty, propelling Mouwasat as a hallmark of trust and reliability within the Saudi healthcare landscape.